Message below is a paid advertisement. Content is provided by the sponsor.
 
What next for small molecules? If you can’t see this email click here
Lonza Pharma & Biotech
Event: CPhl / October 24-26, 2017 the next challenge in small molecules... Let's solve it together.
Hello,
 
There are huge opportunities for drug developers today. Drug candidates have become increasingly innovative, complex and highly potent. For patients, drastically improved treatment options are now within reach.

At the same time, the complexity of new molecules creates new challenges for development and manufacturing. Development timelines have gotten shorter. Investments in programs must be paced. And of course market demand is highly uncertain.

Lonza Pharma & Biotech can work with you to develop and manufacture your next medical innovation.

We aim to increase your chances of business success. We have adapted our offering to the new market challenges. We can meet agile development needs and de-risk manufacture for you.

Our services span from pre-clinical development to commercialization, across API and drug product. We have also expanded our depth of technology and expertise with our recent acquisitions of Capsugel and Micro-Macinazione.

Learn more about how we can support your programs. Visit our website or see us at CPhI Worldwide, Booth 11.1C30, Hall 11.1.

We look forward to seeing you there.
 
visit our website
visit our booth
Unsubscribe
                                                           
 
You received this email because you are a customer of Pharmaceutical Technology, a UBM publication. You are on the mailing list as %%emailaddress%%.